June 05, 2017
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Imprimis reports $5 million net loss in first quarter
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Imprimis Pharmaceuticals reported a net loss of $5 million, or $0.26 per common share, in the first quarter of 2017 compared with a net loss of $4.5 million, or $0.43 per common share, in the same quarter of 2016.
Total revenue for the quarter was $6.1 million, an increase of 39% from 2016’s first quarter of $4.4 million, according to a company press release.
Ophthalmology-related sales increased 105% to $3.7 million compared with $1.8 million last year.
Selling and marketing expenses totaled $2.4 million, while general and administrative expenses totaled $4.4 million.